triazoles has been researched along with haloperidol in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 12 (46.15) | 29.6817 |
| 2010's | 7 (26.92) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Baraboĭ, VA; Bezdrobnaia, LK; Iavorovskiĭ, AP; Iurzhenko, NN; Ovsiannikova, LM; Poberezkina, NB; Potikha, NN; Revo, VI; Sadovaia, SG | 1 |
| Horiuchi, M; Ibii, N; Yamamoto, K | 1 |
| Barbhaiya, RH; Breul, HP; Greene, DS; Midha, KK; Shukla, UA | 1 |
| Farré, AJ; Guitart, X | 1 |
| Cozzolino, A; Morelli, M; Pinna, A; Wardas, J | 1 |
| Konieczny, J; Lorenc-Koci, E; Wardas, J | 1 |
| Bertorelli, R; Costentin, J; El Yacoubi, M; Ledent, C; Ongini, E; Parmentier, M; Vaugeois, JM | 1 |
| Born, C; Grunze, H; Marcuse, A; Schärer, LO; Walden, J | 1 |
| Berk, M; Wynchank, D | 1 |
| Dziedzicka-Wasylewska, M; Pietraszek, M; Wardas, J | 1 |
| Costentin, J; El Yacoubi, M; Vaugeois, JM | 1 |
| Alanko, K; Hannu, T; Keskinen, H | 1 |
| Grzelak, ME; Hodgson, RA; Hunter, JC; Parker, EM; Pond, AJ; Varty, GB | 1 |
| Arik, L; Bertorelli, R; Cohen-Williams, M; Foster, C; Fredduzzi, S; Greenlee, WJ; Hao, J; Lachowicz, J; Liu, H; Neustadt, BR; Ng, K; Stamford, AW; Varty, G; Zhang, H | 1 |
| Dziubina, A; Gołembiowska, K; Kamińska, K; Kowalska, M | 1 |
| Goode, T; Harris, A; Trevitt, J; Vallance, C | 1 |
| Barodia, SK; Kumar, JB; Kumari, R; Luthra, PM; Mishra, CB; Prakash, A | 1 |
| Eyanagi, R; Imoto, M; Kuroki, H; Nishimura, S; Shimeno, H; Soeda, S; Toda, A; Uchiyama, H; Watanabe, S | 1 |
| Amalric, M; Blobaum, AL; Bode, J; Bridges, TM; Bubser, M; Conn, PJ; Daniels, JS; Dickerson, JW; Engers, DW; Hopkins, CR; Italiano, K; Jadhav, S; Jones, CK; Lindsley, CW; Morrison, RD; Niswender, CM; Thompson, AD; Turle-Lorenzo, N | 1 |
| Bleickardt, CJ; Hodgson, RA; Hunter, JC; Jones, NT; Kazdoba, TM | 1 |
| Chaki, S; Hiyoshi, T; Kambe, D; Karasawa, J | 1 |
| Borsini, F; Caprioli, A; Di Serio, S; Lombardo, K; Minetti, P; Pace, S; Riccioni, T; Stasi, MA; Vertechy, M | 1 |
| Burdi, DF; Campbell, JE; Campbell, U; Engel, S; Hewitt, MC; Jones, PG; Lew, R; Quinton, MS | 1 |
| Alcayaga, J; Allende, ML; De la Paz, JF; Paredes-Zúñiga, S; Trost, N | 1 |
| Cao, L; Chang, G; Huang, Y; Xu, Y; Yang, L; Yin, Q | 1 |
| Bai, WB; Jian, RK; Lin, YC; Pang, FQ | 1 |
3 trial(s) available for triazoles and haloperidol
| Article | Year |
|---|---|
Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Biotransformation; Double-Blind Method; Drug Interactions; Half-Life; Haloperidol; Humans; Male; Piperazines; Psychomotor Performance; Triazoles | 1996 |
Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Retrospective Studies; Treatment Outcome; Triazoles | 2002 |
Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.
Topics: Acute Disease; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Female; Haloperidol; Humans; Male; Piperazines; Receptors, Serotonin, 5-HT2; Schizophrenia; Serotonin Antagonists; Substance-Related Disorders; Triazoles | 2003 |
23 other study(ies) available for triazoles and haloperidol
| Article | Year |
|---|---|
[The dynamics of the indices of lipid peroxidation and antioxidative activity in prolonged experimental exposure to epoxy compounds].
Topics: Animals; Antioxidants; Dose-Response Relationship, Drug; Epoxy Resins; Lipid Peroxidation; Male; Rats; Triazoles | 1991 |
[Pharmacology of a 1H-1, 2, 4-triazolyl benzophenone derivative (450191-S), a new sleep-inducer (III). Behavioral study on interactions of 450191-S and other drugs in mice].
Topics: Aminopyrine; Animals; Anti-Anxiety Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Central Nervous System; Central Nervous System Agents; Haloperidol; Hypnotics and Sedatives; Imipramine; Male; Mice; Pentylenetetrazole; Phenytoin; Reserpine; Triazoles | 1984 |
The effect of E-5842, a sigma receptor ligand and potential atypical antipsychotic, on Fos expression in rat forebrain.
Topics: Animals; Antipsychotic Agents; Blotting, Western; Clozapine; Gene Expression; Haloperidol; Ligands; Male; Nucleus Accumbens; Oncogene Proteins v-fos; Prefrontal Cortex; Prosencephalon; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Triazoles | 1998 |
Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol.
Topics: Animals; Antipsychotic Agents; Clozapine; Gene Expression; Genes, fos; Haloperidol; Male; Neurons; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Triazoles | 1999 |
SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Ankle Joint; Dopamine Agents; Dopamine Antagonists; Drug Combinations; Electromyography; Haloperidol; Levodopa; Male; Muscle Contraction; Muscle Rigidity; Muscle, Skeletal; Neostriatum; Neuroprotective Agents; Parkinsonian Disorders; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reserpine; Triazoles | 2001 |
Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blepharoptosis; Disease Models, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Immobilization; Male; Mice; Mice, Knockout; Motor Activity; Purinergic P1 Receptor Antagonists; Purines; Pyrimidines; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Purinergic P1; Reserpine; Swimming; Time Factors; Triazoles | 2001 |
SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum.
Topics: Analysis of Variance; Animals; Brain Mapping; Catalepsy; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Gene Expression Regulation; Haloperidol; In Situ Hybridization; Male; Nucleus Accumbens; Protein Precursors; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Reaction Time; Receptor, Adenosine A2A; RNA, Messenger; Triazoles | 2003 |
Adenosine A2A receptors and depression.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Caffeine; Depression; Disease Models, Animal; Dopamine Antagonists; Drug Interactions; Haloperidol; Mice; Mice, Knockout; Motor Activity; Neurotransmitter Agents; Parkinsonian Disorders; Purines; Pyrimidines; Receptor, Adenosine A2A; Triazines; Triazoles | 2003 |
Anaphylaxis and allergic contact urticaria from occupational airborne exposure to HBTU.
Topics: Adult; Air Pollutants, Occupational; Anaphylaxis; Dermatitis, Allergic Contact; Dermatitis, Occupational; Epinephrine; Epoxy Resins; Histamine H1 Antagonists; Humans; Laboratory Chemicals; Male; Medical Laboratory Personnel; Triazoles; Urea; Urticaria | 2006 |
The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antipsychotic Agents; Caffeine; Catalepsy; Cebus; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Globus Pallidus; Haloperidol; Neurologic Examination; Purines; Pyrimidines; Receptor, Adenosine A2A; Saimiri; Triazoles; Xanthines | 2008 |
Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines.
Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Animals; Area Under Curve; Catalepsy; Chemistry, Pharmaceutical; Drug Design; Haloperidol; Models, Chemical; Parkinson Disease; Pyrimidines; Rats; Structure-Activity Relationship; Triazoles | 2009 |
Effect of adenosine A(2A) receptor antagonists on L-DOPA-induced hydroxyl radical formation in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Area Under Curve; Benserazide; Catalepsy; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Homovanillic Acid; Hydroxyl Radical; Levodopa; Male; Microdialysis; Rats; Rats, Wistar; Time Factors; Triazines; Triazoles; Xanthines | 2009 |
Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease.
Topics: Animals; Caffeine; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Male; Parkinson Disease; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles | 2009 |
In silico study of naphtha [1, 2-d] thiazol-2-amine with adenosine A 2A receptor and its role in antagonism of haloperidol-induced motor impairments in mice.
Topics: Adenosine A2 Receptor Antagonists; Animals; Corpus Striatum; Dopamine; Haloperidol; Humans; Male; Mice; Models, Molecular; Motor Activity; Movement Disorders; Naphthalenes; Receptor, Adenosine A2A; Thiazoles; Triazoles | 2009 |
The stimulatory effects of caffeine with oseltamivir (Tamiflu) on light-dark behavior and open-field behavior in mice.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Antiviral Agents; Caffeine; Darkness; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Exploratory Behavior; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; Haloperidol; Male; Mice; Motor Activity; Neurotransmitter Agents; Oseltamivir; Pyrimidines; Random Allocation; Triazoles; Xanthines | 2010 |
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Brain; Calcium Signaling; Catalepsy; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Glutamic Acid; Haloperidol; HEK293 Cells; Humans; Levodopa; Male; Monoamine Oxidase; Motor Neuron Disease; Oxidopamine; Parkinson Disease; Picolinic Acids; Protein Binding; Psychomotor Performance; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reaction Time; Receptors, G-Protein-Coupled; Receptors, Metabotropic Glutamate; Substantia Nigra; Thallium; Transfection; Triazoles; Tyrosine 3-Monooxygenase | 2012 |
Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model.
Topics: Adenosine A2 Receptor Antagonists; Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Cebus; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Motor Activity; Phosphodiesterase Inhibitors; Piperazines; Pyrazoles; Pyrimidines; Quinolines; Quinolones; Triazoles | 2014 |
Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
Topics: Amino Acids; Animals; Antipsychotic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Clozapine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Electrodes, Implanted; Electroencephalography; Excitatory Amino Acid Antagonists; Fluorobenzenes; GABA Agents; Gamma Rhythm; gamma-Aminobutyric Acid; Glutamic Acid; Haloperidol; Male; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Metabotropic Glutamate; Riluzole; Triazoles | 2014 |
Animal models of Parkinson׳s disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535).
Topics: Adenine; Adenosine A2 Receptor Antagonists; Administration, Oral; Animals; Antiparkinson Agents; Basal Ganglia; Binding, Competitive; Catalepsy; Cyclic AMP; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; HEK293 Cells; Humans; Injections, Intraperitoneal; Ligands; Male; Mice; Motor Activity; Oxidopamine; Parkinsonian Disorders; Protein Binding; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Transfection; Triazoles | 2015 |
Pharmacological evaluation of a novel phosphodiesterase 10A inhibitor in models of antipsychotic activity and cognition.
Topics: Animals; Antipsychotic Agents; Benzimidazoles; Catalepsy; Cognition; Corpus Striatum; Cyclic GMP; Electroencephalography; Haloperidol; Humans; Male; Microdialysis; Motor Activity; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Sleep, REM; Triazoles | 2015 |
Behavioral effects of triadimefon in zebrafish are associated with alterations of the dopaminergic and serotonergic pathways.
Topics: Aggression; Animals; Anxiety; Behavior, Animal; Benzazepines; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Gene Expression; Haloperidol; Hydrocortisone; Larva; Male; Motor Activity; Serotonin; Triazoles; Water Pollutants; Zebrafish | 2019 |
A Toughening and Anti-Counterfeiting Benzotriazole-Based High-Performance Polymer Film Driven by Appropriate Intermolecular Coordination Force.
Topics: Epoxy Resins; Polymers; Triazoles | 2021 |
Facile construction of lamellar-like phosphorus-based triazole-zinc complex for high-performance epoxy resins.
Topics: Epoxy Resins; Hot Temperature; Phosphorus; Triazoles; Zinc | 2022 |